Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience
Rob H. Creemers(Zuyderland Medisch Centrum), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Sjaak Bloem(Nyenrode Business University)
Cited by 4
Related Papers
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
|Nature Clinical Practice Gastroenterology & Hepatology|2007|129
Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2012|102
Dose-Dependent Influence of 5-Aminosalicylates on Thiopurine Metabolism
|The American Journal of Gastroenterology|2007|101
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
|Journal of Crohn s and Colitis|2017|94
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
|Alimentary Pharmacology & Therapeutics|2020|87